Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14612531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis.

  2003cited by this paper
• Fatty acid synthase expression in melanoma

  2003cited by this paper
• Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study.

  2003cited by this paper
• RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells.

  2003cited by this paper
• Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer

  2002cited by this paper
• C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity

  2002cited by this paper
• Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach

  2002cited by this paper
• Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.

  2002cited by this paper
• Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.

  2001cited by this paper
• Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.

  2001cited by this paper
• Increased fatty acid synthase as a therapeutic target in androgen‐independent prostate cancer progression

  2001cited by this paper
• Increased fatty acid synthase is a therapeutic target in mesothelioma.

  2001cited by this paper
• Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53.

  2001cited by this paper
• Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology.

  2000cited by this paper
• Selective activation of the fatty acid synthesis pathway in human prostate cancer

  2000cited by this paper
• Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells.

  2000cited by this paper
• Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.

  2000cited by this paper
• Synthesis and antitumor activity of an inhibitor of fatty acid synthase.

  2000cited by this paper
• Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors.

  2000cited by this paper
• The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.

  2000cited by this paper
• Synthesis and antitumor activity of an inhibitor of fatty acid synthase

  2000cited by this paper
• Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue

  1999cited by this paper
• Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.

  1999cited by this paper
• Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen, and p53 expression in hyperplastic parathyroids.

  1999cited by this paper
• Fatty acid synthase expression in endometrial carcinoma

  1998cited by this paper
• Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines.

  1998cited by this paper
• Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival.

  1997cited by this paper
• Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia.

  1997cited by this paper
• Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2.

  1997cited by this paper
• The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

  1997cited by this paper
• Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.

  1997cited by this paper
• Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling.

  1997cited by this paper
• Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer.

  1996cited by this paper
• Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients

  1996cited by this paper
• OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate.

  1995cited by this paper
• Improvement of Myocardial Function and Metabolism in Diabetic Rats by the Carnitine Palmitoyl Transferase Inhibitor Etomoxir®

  1995cited by this paper
• Coordination of membrane phospholipid synthesis with the cell cycle.

  1994cited by this paper
• Fatty acid synthesis: a potential selective target for antineoplastic therapy.

  1994cited by this paper
• Fatty acid synthase, a proficient multifunctional enzyme.

  1989cited by this paper
• Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria.

  1984cited by this paper
• Purification and crystallization of rat liver fatty acid synthetase.

  1981cited by this paper

• Fatty Acid Synthase as a Potential Metabolic Vulnerability in Ocular Adnexal Sebaceous Carcinoma

  2026cites this paper
• FAM-related prognostic molecular subtype screening identified epithelial-derived MAOA-inhibiting bladder cancer

  2026cites this paper
• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment

  2025cites this paper
• A Potential Role for c-MYC in the Regulation of Meibocyte Cell Stress

  2025cites this paper
• SIRT2‐mediated deacetylation of ACLY promotes the progression of oesophageal squamous cell carcinoma

  2024cites this paper
• AMPK deficiency inhibits fatty acid oxidation in endothelial progenitor cells to aggravate impaired angiogenesis after ischemic stroke in hyperlipidemic mice

  2024cites this paper
• Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways

  2024cites this paper
• Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer

  2023cites this paper
• Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma

  2023cites this paper
• Metabolic reprogramming in cancer: Mechanisms and therapeutics

  2023cites this paper
• Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy

  2023cites this paper
• Two new metabolites from a marine-derived fungus Penicillium ochrochloron

  2023cites this paper
• Inhibition of acetyl-CoA carboxylase impaired tubulin palmitoylation and induced spindle abnormalities

  2023cites this paper
• Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency

  2022cites this paper
• Fatty acid synthase as a potential new therapeutic target for cervical cancer.

  2022cites this paper
• Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.

  2022cites this paper
• Reprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?

  2022cites this paper
• Emerging roles of fatty acid metabolism in cancer and their targeted drug development.

  2022cites this paper
• Nanoemulsion and Encapsulation Strategy of Hydrophobic Oregano Essential Oil Increased Human Prostate Cancer Cell Death via Apoptosis by Attenuating Lipid Metabolism

  2022cites this paper
• Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation

  2022cites this paper
• MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis.

  2021cites this paper
• Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer

  2021cites this paper
• KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism

  2021cites this paper
• Too complex to fail? Targeting fatty acid metabolism for cancer therapy.

  2021cites this paper
• Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

  2021cites this paper
• Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat

  2021cites this paper
• Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

  2021cites this paper
• Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

  2021cites this paper
• Metabolic Modifications, Inflammation, and Cancer Immunotherapy

  2021cites this paper
• Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC

  2021cites this paper
• Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase.

  2021cites this paper
• MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer

  2020cites this paper
• Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma

  2020cites this paper
• Lipid-mediated regulation of the cancer-immune crosstalk.

  2020cites this paper
• Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells

  2020cites this paper
• Inhibitors of lipogenic enzymes as a potential therapy against cancer

  2020cites this paper
• The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival

  2020cites this paper
• Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function

  2019cites this paper
• Drugging cancer metabolism: Expectations vs. reality.

  2019cites this paper
• Aberrant lipid metabolism as a therapeutic target in liver cancer

  2019cites this paper
• FASN activity is important for the initial stages of the induction of senescence

  2019cites this paper
• Proteinexpression von UBE2C, TOP2A, FASN, CCNB1 CDC2 und Ki-67 im Ovarialkarzinom zur Trennung von Low-grade und High-grade

  2019cites this paper
• Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target

  2019cites this paper
• Lipid metabolism reprogramming and its potential targets in cancer

  2018cites this paper
• Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk

  2018cites this paper
• Analysis of potential driver genes in oral squamous cell carcinoma

  2018cites this paper
• Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties

  2018cites this paper
• Role of Oxidative and Nitro-Oxidative Damage in Silver Nanoparticles Cytotoxic Effect against Human Pancreatic Ductal Adenocarcinoma Cells

  2018cites this paper
• Glutamine Deprivation Enhances Acetyl-CoA Carboxylase Inhibitor-induced Death of Human Pancreatic Cancer Cells

  2018cites this paper
• Cancer Metabolism: Current Understanding and Therapies.

  2018cites this paper
• Suppressed de novo lipogenesis by plasma membrane citrate transporter inhibitor promotes apoptosis in HepG2 cells

  2018cites this paper
• JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.

  2018cites this paper
• Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics.

  2018cites this paper
• Ethyl acetate fraction of garlic (Allium sativum) inhibits the viability of MCF7 and HepG2 through induction of apoptosis and G2/M phase cell cycle arrest

  2018cites this paper
• Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.

  2017cites this paper
• A computational model of hepatic energy metabolism: Understanding the role of zonation in the development and treatment of non-alcoholic fatty liver disease (NAFLD).

  2017cites this paper
• Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model

  2017cites this paper
• MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway

  2017cites this paper
• (-)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects.

  2017cites this paper
• Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress

  2017cites this paper
• Clove extract functions as a natural fatty acid synthesis inhibitor and prevents obesity in a mouse model.

  2017cites this paper
• Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis.

  2017cites this paper
• Fatty acid synthase (FASN) as a therapeutic target in breast cancer

  2017cites this paper
• Defining the Interactome and Functional Regulation of the O-GlcNAcase Enzyme During Oxidative Stress

  2017cites this paper
• Distribution of enantiomers of volatile organic compounds in selected fruit distillates.

  2017cites this paper
• Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells

  2017cites this paper
• Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells

  2017cites this paper
• A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.

  2017cites this paper
• Patuletin induces apoptosis of human breast cancer SK-BR-3 cell line via inhibiting fatty acid synthase gene expression and activity.

  2017cites this paper
• Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas

  2017cites this paper
• Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands

  2017cites this paper
• In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes.

  2017cites this paper
• Quercetin induces apoptosis in triple-negative breast cancer cells via inhibiting fatty acid synthase and β-catenin

  2016cites this paper
• Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75

  2016cites this paper
• The multifaceted roles of fatty acid synthesis in cancer

  2016cites this paper
• Leptin regulates energy metabolism in MCF-7 breast cancer cells.

  2016cites this paper
• Trimming the fat in non-small cell lung cancer: a new small molecule inhibitor of acetyl-CoA carboxylase to target fatty acid synthesis

  2016cites this paper
• O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes

  2016cites this paper
• Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer

  2016cites this paper
• Targeting metabolism in breast cancer: How far we can go?

  2016cites this paper
• Metabolic Regulation of Apoptosis in Cancer.

  2016cites this paper
• Regulation of Programmed Cell Death and Lipid Droplet Formation by CTP:Phosphocholine Cytidylyltransferase Alpha (CCTα)

  2016cites this paper
• Novel drugs that target the metabolic reprogramming in renal cell cancer

  2016influential citation
• The effects of conjugated linoleic acids on breast cancer: A systematic review

  2016cites this paper
• Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection

  2016cites this paper
• MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway.

  2016cites this paper
• TARGETING LEUKEMIA CELL METABOLISM

  2015cites this paper
• [6]-Gingerol inhibits de novo fatty acid synthesis and carnitine palmitoyltransferase-1 activity which triggers apoptosis in HepG2.

  2015cites this paper
• Proteomic approaches for identifying new mechanisms of action and pharmacodynamic biomarkers of resveratrol in colorectal cancer

  2015cites this paper
• Global Gene Deregulations in FASN Silenced Retinoblastoma Cancer Cells: Molecular and Clinico‐Pathological Correlations

  2015cites this paper
• Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy

  2015cites this paper
• The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways

  2015cites this paper
• Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway

  2015cites this paper
• The acetyl-CoA carboxylase enzyme: a target for cancer therapy?

  2015cites this paper
• Molecular Pathways: Fatty Acid Synthase

  2015cites this paper
• Dual inhibition of EGFR at protein and activity level via combinatorial blocking of PI4KIIα as anti-tumor strategy

  2014cites this paper
• Metformin—mode of action and clinical implications for diabetes and cancer

  2014cites this paper
• Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis

  2014cites this paper
• Crystal Structure of the Human Fatty Acid Synthase Enoyl-Acyl Carrier Protein-Reductase Domain Complexed with Triclosan Reveals Allosteric Protein-Protein Interface Inhibition*

  2014cites this paper
• Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells

  2014cites this paper